Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs QuickMD

By GLP-1 ScorecardUpdated

AgelessRx
Site position #17

Higher score

QuickMDFactor scores not reassessed.
Site position #248

Lower score

Score comparison

AgelessRx has the higher recorded score — 84.3/100 to 64.9/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.

Before you choose

QuickMD does not publish a tirzepatide price, so its QuickMD review sets out what it does disclose, while the AgelessRx review explains the conditions attached to AgelessRx's figure. The tirzepatide cost page compares published rates across the field. Ask QuickMD for a written total before treating either one as the cheaper choice.

If neither one fits, AgelessRx vs Ravia Health and CoreAge Rx vs QuickMD compare each of them with another graded program, and the list of alternatives to AgelessRx ranks the programs closest to AgelessRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the HealthRX review covers one graded close to these two, at 77.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueAgelessRx +45
90
45
Dose & formulationAgelessRx +4
80
76
Clinical oversightQuickMD +3
83
86
Labs & monitoringAgelessRx +30
82
52
FulfillmentAgelessRx +13
84
71
Contract termsAgelessRx +24
85
61
AgelessRx · top barQuickMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAgelessRxQuickMD
WeighScore84.3/10064.9/100
GradeBC
Site position#17#248
SemaglutideNot verified (current medication-specific quote required)Medication priced separately by pharmacy
TirzepatideMicrodose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote requiredMedication priced separately by pharmacy
CoverageAdvertises US service; confirm treatment-specific state availabilityConfirm weight-loss visits in your state
Brand-name accessYesYes
Oral / sublingualYesYes
AgelessRx

Site position #17 · B

Strengths

  • Conventional and lower-dose GLP-1 programs advertised
  • Wegovy pens and oral-tablet consultations advertised
  • Continuing messaging and check-ins advertised

What to consider

  • Conventional medication-specific monthly quotes not verified
  • Microdose introduction renews as a two-month charge
  • Branded medication has a separate pharmacy bill
  • Treatment-specific state eligibility and assigned dispenser need confirmation
QuickMD

Site position #248 · C

Factor scores not reassessed.

Strengths

  • Publishes a standalone visit price
  • No membership advertised for weight-loss visits
  • Clinician can send an appropriate prescription to a local pharmacy

What to consider

  • Pharmacy charge depends on the prescription and coverage
  • Completed visits are nonrefundable even without a prescription
  • Missed or late-canceled visits incur a $35 deduction from visit credit

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard